BRPI0518172A - prevenção de infecções verticais com endoparasitas - Google Patents

prevenção de infecções verticais com endoparasitas

Info

Publication number
BRPI0518172A
BRPI0518172A BRPI0518172-0A BRPI0518172A BRPI0518172A BR PI0518172 A BRPI0518172 A BR PI0518172A BR PI0518172 A BRPI0518172 A BR PI0518172A BR PI0518172 A BRPI0518172 A BR PI0518172A
Authority
BR
Brazil
Prior art keywords
prevention
vertical
infections
endoparasite infections
vertical endoparasite
Prior art date
Application number
BRPI0518172-0A
Other languages
English (en)
Inventor
Thomas Bach
Janina Taenzler
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of BRPI0518172A publication Critical patent/BRPI0518172A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)

Abstract

PREVENçãO DE INFECçõES VERTICAIS COM ENDOPARASITAS. A presente invenção refere-se ao uso de depsipeptideos endoparasiticidas para produção de medicamentos para a prevenção de infecções verticais com endoparasitas.
BRPI0518172-0A 2004-11-16 2005-11-03 prevenção de infecções verticais com endoparasitas BRPI0518172A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004055316A DE102004055316A1 (de) 2004-11-16 2004-11-16 Verhinderung vertikaler Endoparasiten-Infektionen
PCT/EP2005/011748 WO2006053641A1 (de) 2004-11-16 2005-11-03 Verhinderung vertikaler endoparasiten-infektionen

Publications (1)

Publication Number Publication Date
BRPI0518172A true BRPI0518172A (pt) 2008-11-04

Family

ID=35767587

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0518172-0A BRPI0518172A (pt) 2004-11-16 2005-11-03 prevenção de infecções verticais com endoparasitas

Country Status (30)

Country Link
US (1) US20090215678A1 (pt)
EP (1) EP1814572B1 (pt)
JP (1) JP5078619B2 (pt)
KR (1) KR101280511B1 (pt)
CN (1) CN101102785B (pt)
AR (1) AR052133A1 (pt)
AT (1) ATE469652T1 (pt)
AU (1) AU2005306070B2 (pt)
BR (1) BRPI0518172A (pt)
CA (1) CA2587537C (pt)
CR (1) CR9108A (pt)
DE (2) DE102004055316A1 (pt)
DK (1) DK1814572T3 (pt)
ES (1) ES2345265T3 (pt)
HK (1) HK1117041A1 (pt)
HR (1) HRP20100471T1 (pt)
IL (1) IL183200A (pt)
MX (1) MX2007005766A (pt)
MY (1) MY142727A (pt)
NO (1) NO341472B1 (pt)
NZ (1) NZ555117A (pt)
PE (1) PE20061079A1 (pt)
PL (1) PL1814572T3 (pt)
PT (1) PT1814572E (pt)
RU (1) RU2405565C2 (pt)
SI (1) SI1814572T1 (pt)
TW (1) TWI358293B (pt)
UA (1) UA91694C2 (pt)
WO (1) WO2006053641A1 (pt)
ZA (1) ZA200703982B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008022520A1 (de) * 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
CN104023710A (zh) * 2011-12-21 2014-09-03 拜耳知识产权有限责任公司 包含无定形艾默德斯的制剂
MX2021001566A (es) 2015-05-20 2022-09-12 Boehringer Ingelheim Animal Health Usa Inc Compuestos depsipeptidicos como anthelminticos.
JP6943859B2 (ja) 2015-12-28 2021-10-06 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性デプシペプチド化合物
US11382949B2 (en) 2016-11-16 2022-07-12 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
CN111757880A (zh) 2017-11-07 2020-10-09 拜耳动物保健有限责任公司 用于合成环状缩肽的方法
EP3480195A1 (en) 2017-11-07 2019-05-08 Bayer Animal Health GmbH Method for the synthesis of cyclic depsipeptides

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2362539C2 (de) * 1973-12-17 1986-05-07 Merck Patent Gmbh, 6100 Darmstadt 2-Acyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
NO176766C (no) * 1989-02-07 1995-05-24 Meiji Seika Kaisha Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
DE122005000058I1 (de) * 1992-03-17 2006-04-27 Astellas Pharma Inc Depsipeptide, Herstellung und Anwendung
DE4317458A1 (de) * 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
CA2155871A1 (en) * 1993-02-19 1994-09-01 Makoto Ohyama Derivatives of cyclodepsipeptide pf 1022
ATE143601T1 (de) * 1993-05-05 1996-10-15 Palo Alto Medical Found Verwendung von rifamycinderivaten zur herstellung eines arzneimittels zur behandlung der toxoplasmose
DE4317457A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317432A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
EP0718293B1 (en) * 1993-09-06 2002-03-13 Fujisawa Pharmaceutical Co., Ltd. Cyclodepsipeptide compound
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
DE4401389A1 (de) * 1994-01-19 1995-07-20 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 12 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 12 Ringatomen und Verfahren zu ihrer Herstellung
DE4406025A1 (de) * 1994-02-24 1995-08-31 Bayer Ag Milchsäure-haltige cyclische Depsipeptide mit 18 Ringatomen als endoparasitizide Mittel und Verfahren zu ihrer Herstellung
DE4437198A1 (de) * 1994-10-18 1996-04-25 Bayer Ag Verfahren zur Sulfonylierung, Sulfenylierung und Phosphorylierung von cyclischen Depsipeptiden
CN1162409C (zh) * 1995-06-30 2004-08-18 藤泽药品工业株式会社 缩肽衍生物、其新型中间体以及中间体的制造方法
WO1997011064A1 (fr) * 1995-09-22 1997-03-27 Meiji Seika Kaisha, Ltd. Nouveaux derives depsipeptides cycliques de pf1022
DE19545639A1 (de) * 1995-12-07 1997-06-12 Bayer Ag Verfahren zur Herstellung von substituierten Arylmilchsäure-haltigen Cyclodepsipeptiden mit 24 Ringatomen
DE19962147A1 (de) * 1999-12-22 2001-06-28 Bayer Ag Schädlingsbekämpfungsmittel / PF 1022-221
US20010036922A1 (en) * 2000-04-03 2001-11-01 Benchaoui Hafid Abdelaali Method of treating a parasitic infection
GB0008353D0 (en) * 2000-04-03 2000-05-24 Pfizer Ltd Method of treating a parasitic infection
DE10358525A1 (de) * 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel

Also Published As

Publication number Publication date
NO341472B1 (no) 2017-11-20
DE102004055316A1 (de) 2006-05-18
CN101102785B (zh) 2011-05-18
UA91694C2 (ru) 2010-08-25
KR101280511B1 (ko) 2013-07-01
EP1814572A1 (de) 2007-08-08
RU2007122284A (ru) 2008-12-27
ATE469652T1 (de) 2010-06-15
IL183200A0 (en) 2007-08-19
PL1814572T3 (pl) 2010-11-30
DE502005009697D1 (de) 2010-07-15
CA2587537A1 (en) 2006-05-26
AU2005306070B2 (en) 2011-05-12
WO2006053641A1 (de) 2006-05-26
AU2005306070A1 (en) 2006-05-26
ES2345265T3 (es) 2010-09-20
HK1117041A1 (en) 2009-01-09
TW200626140A (en) 2006-08-01
CR9108A (es) 2007-09-11
MX2007005766A (es) 2007-07-16
TWI358293B (en) 2012-02-21
CN101102785A (zh) 2008-01-09
MY142727A (en) 2010-12-31
NZ555117A (en) 2009-11-27
HRP20100471T1 (hr) 2010-10-31
JP5078619B2 (ja) 2012-11-21
NO20073023L (no) 2007-08-10
EP1814572B1 (de) 2010-06-02
ZA200703982B (en) 2008-08-27
CA2587537C (en) 2014-06-03
KR20070084412A (ko) 2007-08-24
AR052133A1 (es) 2007-03-07
PE20061079A1 (es) 2006-11-30
PT1814572E (pt) 2010-08-02
DK1814572T3 (da) 2010-09-20
IL183200A (en) 2011-12-29
JP2008520598A (ja) 2008-06-19
US20090215678A1 (en) 2009-08-27
RU2405565C2 (ru) 2010-12-10
SI1814572T1 (sl) 2010-09-30

Similar Documents

Publication Publication Date Title
BRPI0509184A (pt) composições farmacêuticas
CR10157A (es) Compuestos químicos
BRPI0518172A (pt) prevenção de infecções verticais com endoparasitas
CL2007003244A1 (es) Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
NI201000055A (es) 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa.
UY28662A1 (es) Agente endoparasiticida para administracion topica
CL2007003797A1 (es) Compuestos derivados de pirrolo piridina; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de la enfermedad de alzheimer, parkinson, cancer, entre otras enfermedades.
CL2007002594A1 (es) Compuestos derivados de piridin-3-il, agentes inmunomoduladores; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de enfermedades asociadas con un sistema inmunologico activado. .
ATE528989T1 (de) Kristalline feste rasagilin-base
TW200745161A (en) Stable antibody formulation
BRPI0618239A8 (pt) uso de flibanserina para o tratamento de distúrbios de desejo sexual pré-menopáusicos
ATE540680T1 (de) Pharmazeutische aripiprazol-zusammensetzungen
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
ECSP11011054A (es) Péptidos antivirales terapéuticos
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
CL2007001838A1 (es) Compuestos derivados de 4-oxoquinolina; composicion farmaceutica; y uso del compuesto para la produccion de un agente anti-vih.
CY1110658T1 (el) Χρηση του καρραγηνου για τη θεραπεια μολυνσεων απο ρινοϊο
SV2011003827A (es) Uso de dronedarona para la preparacion de un medicamento para la prevencion de ictus o ataque isquemico transitorio
ECSP10010661A (es) Dronedarona para la prevención de la cardioversión
EA200970353A1 (ru) Комбинированное лекарственное средство
BRPI0618370A2 (pt) formulação aerossol de medicamento, uso do mesmo e kit de inalação
GT200600010A (es) Procedimientos para la preparacion de alcoholes aminoetoxibencilicos
BRPI0409175A (pt) preparação farmacêutica oral para antagonistas de bombeamento de próton
ATE473233T1 (de) Neue morphinderivate
EA200901387A1 (ru) Фармацевтическая композиция, включающая дезлоратадин

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: BAYER ANIMAL HEALTH GMBH (DE)

Free format text: TRANSFERIDO DE: BAYER HEALTHCARE AG

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: BAYER INTELLECTUAL PROPERTY GMBH (DE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07C Technical examination (opinion): republication [chapter 7.3 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.